Eurofarma has operations in 22 nations in Latina America, Africa and North America.

Since the company carried out these internationalization movements, all areas of the company have been working hard to integrate operations. The goal is to improve local management and replicate Eurofarma's current business model in these countries, transforming the company more and more into a global organization.

Eurofarma’s internationalization process began in 2009, with the acquisition of the Argentine company Quesada. Today, the Unit operates exclusively in the private sector. It markets products for the cardiology, general practice, gastroenterology and psychiatry specialties. The purchase agreement for the Mirador plant in Argentina, belonging to the Sanofi laboratory, was completed in 2016. To learn more about Eurofarma Argentina, visit www.eurofarmaargentina.com.ar

To learn more about Eurofarma Argentina, visit https://www.eurofarmaargentina.com.ar.

Laboratório Gautier, a traditional company in the Uruguayan market, began its activities in Bolivia in 2001. Today, this subsidiary operates as Eurofarma Bolivia and covers the areas of prescription drugs and bidding. The unit markets products for the cardiology, surgery, general practice, endocrinology, gastroenterology, gynecology, neurology, orthopedics, otorhinolaryngology, pediatrics, psychiatry and urology specialties.

To learn more about Eurofarma Bolivia, visit www.eurofarma.com.bo/ To learn more about Eurofarma Bolivia, visit www.eurofarma.com.bo.

Founded in 1972, Eurofarma in Brazil has over 12,000 employees and one of the largest sales and medical propaganda workforces in the country. Eurofarma is currently the Brazilian leader in medical prescriptions, recognized by the medical community and society as a whole for promoting access to health and quality of life with treatments at a fair price, quality and innovation. Its major industrial park in Brazil guarantees the company a prominent place in the main pharmaceutical segments: Prescription Drugs, Nonprescription Drugs, Generic Drugs, Hospital, Bidding, Oncology and Outsourcing Services. The company’s broad portfolio encompasses all medical specialties and is a benchmark for central nervous system, anti-infective and hormonal drugs. To learn more about Eurofarma Brazil, visit eurofarma.com.br

In 2010, with the acquisition of the Volta and Farmindustria laboratory, Eurofarma began its operation in what is one of the most important pharmaceutical markets in Latin America. The two companies were unified under the name Euromed Chile, today Eurofarma. In 2019, the company acquired Medipharm in Chile, expanding its product portfolio and presence in the country. The unit serves the specialties of Cardiology, General Practice, Gastroenterology, Gynecology, Neurology, Otorhinolaryngology, Pediatrics, Psychiatry and Occupational Medicine. Currently, the operation has 355 employees and its three main products are: Aerogastrol, Bisopril and Betina.

To learn more about Eurofarma Chile, visit www.eurofarma.cl

The acquisition of the Merck Sharp & Dohme (MSD) plant in the capital city of Bogota in 2012 marked Eurofarma’s entry to Colombia. The plant occupies an area of approximately 22,000 m2 and produces powdered, injectable, cream, liquid and solid medication, focused on the general practice, dermatology, gynecology, otorhinolaryngology, pediatrics, psychiatry, gastroenterology, gynecology, cardiology, dentistry, orthopedics, neurology and internal medicine specialties.

To learn more about Eurofarma Colombia, visit www.eurofarma.com.co To learn more about Eurofarma Colombia, visit https://www.eurofarma.com.co.

The unit began its operations in 2016, in the country’s capital city of Quito, and already has products for the gynecology, urology, general medicine, oncology, pediatrics and otorhinolaryngology specialties. To learn more about Eurofarma Ecuador, visit www.eurofarma.com.ec

To learn more about Eurofarma Ecuador, visit www.eurofarma.com.ec.

Eurofarma arrived in Guatemala, the 3rd largest country in Central America, in June 2013 with the acquisition of Laprin, the 4th largest prescription drug company in the local market with operations in Belize, Panama, Nicaragua, Honduras, El Salvador, Costa Rica and the Dominican Republic. The plant produces nonprescription drugs for the cardiology, general practice, gastroenterology, gynecology, neurology, orthopedics and traumatology, otorhinolaryngology, pediatrics, psychiatry and occupational medicine specialties. To learn more about Eurofarma Guatemala and Central America, visit www.eurofarma.com.gt

To learn more about Eurofarma Guatemala & Central America, visit www.eurofarma.com.gt.

Eurofarma began its operations in Mexico, one of the largest markets in Latin America, in 2019, marketing hospital products. In 2021 Eurofarma completed the largest acquisition in value for the region, of a portfolio of 12 brand-name drugs and also strengthened its operations in Mexico with the acquisition of a recognized antibiotic, constituting a wide line of innovative and patented products in the areas of oncology, cardiometabolic, respiratory, OTC and mature products for the private and institutional channel, thus consolidating its presence in 100% of Latin America.

For more information about Eurofarma México, visit www.eurofarma.com.mx

Based in the city of Maputo, Eurofarma began its regulatory activities in the country in 2016. The unit currently sells exclusively in the private sector a broad portfolio of products in the specialties of Cardiology, Gastroenterology, Gynecology, Urology, General Medicine, Pediatrics, and Central Nervous System. 

To learn more about Eurofarma Mozambique, visit www.eurofarma.co.mz. To learn more about Eurofarma Mozambique, visit www.eurofarma.co.mz.

Located in the country’s capital, Asunción, the unit began operations in the year 2016. Its portfolio includes products focused on pediatrics, gynecology, traumatology, neurology, psychiatry and general medicine. To learn more about Eurofarma Paraguay, visit www.eurofarma.com.py

To learn more about Eurofarma Paraguay, visit www.eurofarma.com.py.

With over 50 years of experience in Peru, Laboratório Refasa Carrión was acquired by Eurofarma in March 2013. The unit has approximately 200 employees and a production plant, including a broad portfolio of products in the gastroenterology, gynecology and obstetrics, neurology, otorhinolaryngology, pediatrics, pulmonology and psychiatry specialties.

To learn more about Eurofarma Peru, visit www.eurofarma.com.pe To learn more about Eurofarma Peru, visit www.eurofarma.com.pe.

With approximately a century of operations in Uruguay and listed among the top 10 in the country, Laboratório Gautier was acquired by Eurofarma in 2010. Headquartered in Montevideo, it has a significant portfolio and serves the cardiology, general practice, gastroenterology, geriatrics/family medicine, gynecology, neurology, psychiatry, pediatrics, rheumatology and urology specialties. To learn more about Eurofarma Uruguay, visit www.eurofarma.com.uy

To learn more about Eurofarma Uruguay, visit www.eurofarma.com.uy.

Situada em Caracas, a Eurofarma Venezuela iniciou suas atividades em 2016 com produtos voltados à Medicina Geral, Cardiologia, Neurologia, Gastrenterologia e Oncologia. www.eurofarma.co.ve

To learn more about Eurofarma Venezuela, visit https://www.eurofarma.co.ve.